E
QHSLab, Inc.
USAQ
$0.2398
$0.024811.54%
E
Sell
3/14/2023Downgrade
QHSLab, Inc. (USAQ) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index and total return index.
QHSLab, Inc. (USAQ) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index and total return index.
D
Sell
2/23/2023Upgraded
QHSLab, Inc. (USAQ) was upgraded to D- from E+ on 2/23/2023 due to an increase in the valuation index and volatility index.
QHSLab, Inc. (USAQ) was upgraded to D- from E+ on 2/23/2023 due to an increase in the valuation index and volatility index.
E
Sell
2/8/2023Downgrade
QHSLab, Inc. (USAQ) was downgraded to E+ from D- on 02/08/2023.
QHSLab, Inc. (USAQ) was downgraded to E+ from D- on 02/08/2023.
D
Sell
1/27/2023Downgrade
QHSLab, Inc. (USAQ) was downgraded to D- from D on 1/27/2023 due to a decline in the volatility index.
QHSLab, Inc. (USAQ) was downgraded to D- from D on 1/27/2023 due to a decline in the volatility index.
D
Sell
1/12/2023Upgraded
QHSLab, Inc. (USAQ) was upgraded to D from D- on 1/12/2023 due to an increase in the volatility index.
QHSLab, Inc. (USAQ) was upgraded to D from D- on 1/12/2023 due to an increase in the volatility index.
D
Sell
12/28/2022Downgrade
QHSLab, Inc. (USAQ) was downgraded to D- from D on 12/28/2022 due to a large decline in the solvency index, total return index and volatility index. Debt to equity increased from 3.46 to 5.7.
QHSLab, Inc. (USAQ) was downgraded to D- from D on 12/28/2022 due to a large decline in the solvency index, total return index and volatility index. Debt to equity increased from 3.46 to 5.7.
D
Sell
5/5/2022Upgraded
QHSLab, Inc. (USAQ) was upgraded to D from D- on 05/05/2022.
QHSLab, Inc. (USAQ) was upgraded to D from D- on 05/05/2022.
D
Sell
4/20/2022Downgrade
QHSLab, Inc. (USAQ) was downgraded to D- from D on 4/20/2022 due to a decline in the total return index and volatility index.
QHSLab, Inc. (USAQ) was downgraded to D- from D on 4/20/2022 due to a decline in the total return index and volatility index.
D
Sell
11/17/2021Upgraded
USA Equities Corp. (USAQ) was upgraded to D from D- on 11/17/2021 due to an increase in the solvency index, total return index and valuation index. The quick ratio increased from 0.55 to 0.66.
USA Equities Corp. (USAQ) was upgraded to D from D- on 11/17/2021 due to an increase in the solvency index, total return index and valuation index. The quick ratio increased from 0.55 to 0.66.
D
Sell
11/8/2021Downgrade
USA Equities Corp. (USAQ) was downgraded to D- from D on 11/8/2021 due to a significant decline in the efficiency index and valuation index. Net income declined 29.53% from -$86.7 to -$112.3.
USA Equities Corp. (USAQ) was downgraded to D- from D on 11/8/2021 due to a significant decline in the efficiency index and valuation index. Net income declined 29.53% from -$86.7 to -$112.3.
D
Sell
4/15/2020Downgrade
USA Equities Corp. (USAQ) was downgraded to D from D+ on 4/15/2020 due to a significant decline in the solvency index and growth index. EBIT declined 2,001.56% from -$6.4 to -$134.5, operating cash flow declined 1,091.67% from -$9.6 to -$114.4, and earnings per share declined from -$0.0026 to -$0.024.
USA Equities Corp. (USAQ) was downgraded to D from D+ on 4/15/2020 due to a significant decline in the solvency index and growth index. EBIT declined 2,001.56% from -$6.4 to -$134.5, operating cash flow declined 1,091.67% from -$9.6 to -$114.4, and earnings per share declined from -$0.0026 to -$0.024.
D
Sell
11/20/2019Upgraded
USA Equities Corp. (USAQ) was upgraded to D+ from D on 11/20/2019 due to a noticeable increase in the total return index.
USA Equities Corp. (USAQ) was upgraded to D+ from D on 11/20/2019 due to a noticeable increase in the total return index.
D
Sell
11/5/2019Downgrade
USA Equities Corp. (USAQ) was downgraded to D from D+ on 11/5/2019 due to a large decline in the total return index and valuation index.
USA Equities Corp. (USAQ) was downgraded to D from D+ on 11/5/2019 due to a large decline in the total return index and valuation index.
D
Sell
8/23/2019Downgrade
USA Equities Corp. (USAQ) was downgraded to D+ from C- on 8/23/2019 due to a decline in the total return index.
USA Equities Corp. (USAQ) was downgraded to D+ from C- on 8/23/2019 due to a decline in the total return index.
C
Hold
8/7/2019Upgraded
USA Equities Corp. (USAQ) was upgraded to C- from D+ on 8/7/2019 due to an increase in the growth index and valuation index. EBIT increased 71.84% from -$10.3 to -$2.9, and earnings per share increased from -$0.0036 to -$0.0016.
USA Equities Corp. (USAQ) was upgraded to C- from D+ on 8/7/2019 due to an increase in the growth index and valuation index. EBIT increased 71.84% from -$10.3 to -$2.9, and earnings per share increased from -$0.0036 to -$0.0016.
D
Sell
8/24/2018Downgrade
USA Equities Corp. (USAQ) was downgraded to D+ from C- on 8/24/2018 due to a decline in the growth index and efficiency index. Total capital declined 3.12% from -$89.6 to -$92.4.
USA Equities Corp. (USAQ) was downgraded to D+ from C- on 8/24/2018 due to a decline in the growth index and efficiency index. Total capital declined 3.12% from -$89.6 to -$92.4.
C
Hold
8/23/2018Upgraded
USA Equities Corp. (USAQ) was upgraded to C- from D on 8/23/2018 due to a significant increase in the total return index, volatility index and growth index. Operating cash flow increased 100% from -$100 to $0.
USA Equities Corp. (USAQ) was upgraded to C- from D on 8/23/2018 due to a significant increase in the total return index, volatility index and growth index. Operating cash flow increased 100% from -$100 to $0.
D
Sell
4/15/2016Downgrade
USA Equities Corp. (USAQ) was downgraded to D from D+ on 4/15/2016 due to a decline in the total return index, growth index and volatility index.
USA Equities Corp. (USAQ) was downgraded to D from D+ on 4/15/2016 due to a decline in the total return index, growth index and volatility index.
D
Sell
4/4/2016Upgraded
USA Equities Corp. (USAQ) was upgraded to D+ from D on 4/4/2016 due to an increase in the total return index.
USA Equities Corp. (USAQ) was upgraded to D+ from D on 4/4/2016 due to an increase in the total return index.
D
Sell
3/18/2016Downgrade
USA Equities Corp. (USAQ) was downgraded to D from D+ on 3/18/2016 due to a noticeable decline in the total return index and volatility index.
USA Equities Corp. (USAQ) was downgraded to D from D+ on 3/18/2016 due to a noticeable decline in the total return index and volatility index.
D
Sell
3/11/2016Downgrade
USA Equities Corp. (USAQ) was downgraded to D+ from C- on 3/11/2016 due to a major decline in the volatility index and total return index.
USA Equities Corp. (USAQ) was downgraded to D+ from C- on 3/11/2016 due to a major decline in the volatility index and total return index.
C
Hold
11/24/2015Downgrade
USA Equities Corp. (USAQ) was downgraded to C- from C on 11/24/2015 due to a significant decline in the volatility index, growth index and total return index. Operating cash flow declined 30.3% from -$13.2 to -$9.2.
USA Equities Corp. (USAQ) was downgraded to C- from C on 11/24/2015 due to a significant decline in the volatility index, growth index and total return index. Operating cash flow declined 30.3% from -$13.2 to -$9.2.
C
Hold
8/18/2015Downgrade
American Biogenetic Sciences, Inc. (MABA) was downgraded to C from C+ on 8/18/2015 due to a noticeable decline in the total return index.
American Biogenetic Sciences, Inc. (MABA) was downgraded to C from C+ on 8/18/2015 due to a noticeable decline in the total return index.
C
Hold
8/3/2015Upgraded
American Biogenetic Sciences, Inc. (MABA) was upgraded to C+ from C on 8/3/2015 due to a substantial increase in the total return index, growth index and volatility index. Operating cash flow increased 177.14% from -$3.5 to -$9.7.
American Biogenetic Sciences, Inc. (MABA) was upgraded to C+ from C on 8/3/2015 due to a substantial increase in the total return index, growth index and volatility index. Operating cash flow increased 177.14% from -$3.5 to -$9.7.
C
Hold
5/27/2014Upgraded
American Biogenetic Sciences, Inc. (MABA) was upgraded to C from C- on 5/27/2014 due to an increase in the growth index and valuation index.
American Biogenetic Sciences, Inc. (MABA) was upgraded to C from C- on 5/27/2014 due to an increase in the growth index and valuation index.
C
Hold
4/21/2014Upgraded
American Biogenetic Sciences, Inc. (MABA) was upgraded to C- from on 4/21/2014 due to a significant increase in the solvency index, efficiency index and volatility index. Total capital increased 6.51% from -$262.6 to -$279.7, and debt to equity declined from -0.22 to -0.21.
American Biogenetic Sciences, Inc. (MABA) was upgraded to C- from on 4/21/2014 due to a significant increase in the solvency index, efficiency index and volatility index. Total capital increased 6.51% from -$262.6 to -$279.7, and debt to equity declined from -0.22 to -0.21.
OTC PK
03/11/2025 9:55AM Eastern
Quotes delayed
